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Sweden; and §§Department of Physics, Warwick University, Coventry, United KingdomABSTRACT The established correlation between neurodegenerative disorders and intracerebral deposition of polyglutamine
aggregates motivates attempts to better understand their fibrillar structure. We designed polyglutamines with a few lysines in-
serted to overcome the hindrance of extreme insolubility and two D-lysines to limit the lengths of b-strands. One is 33 amino
acids long (PolyQKd-33) and the other has one fewer glutamine (PolyQKd-32). Both form well-dispersed fibrils suitable for anal-
ysis by electron microscopy. Electron diffraction confirmed cross-b structures in both fibrils. Remarkably, the deletion of just one
glutamine residue from the middle of the peptide leads to substantially different amyloid structures. PolyQKd-32 fibrils are
consistently 10–20% wider than PolyQKd-33, as measured by negative staining, cryo-electron microscopy, and scanning trans-
mission electron microscopy. Scanning transmission electron microscopy analysis revealed that the PolyQKd-32 fibrils have
50% higher mass-per-length than PolyQKd-33. This distinction can be explained by a superpleated b-structure model for Pol-
yQKd-33 and a model with two b-solenoid protofibrils for PolyQKd-32. These data provide evidence for b-arch-containing struc-
tures in polyglutamine fibrils and open future possibilities for structure-based drug design.INTRODUCTIONPolyglutamine (polyQ) sequences are found in a variety of
innocuous proteins (1,2), but at least nine human proteins
containing polyQ runs of longer than 20 residues are associ-
ated with severe hereditary neurodegenerative diseases,
including Huntington’s disease, spinobulbar muscular atro-
phy, dentatorubral-pallidoluysian atrophy, and spinocere-
bellar ataxia (3). The disease-related proteins are not
sequence-similar to each other outside of the polyQ regions.
The pathogenic mechanisms of these diseases are not fully
understood but one thing is definite—the brain tissues of
patients contain deposits of the polyQ-rich proteins (4,5).
Furthermore, longer polyQ tracts (>30 residues or so)
have a stronger predisposition to aggregate, leading to a
higher risk and earlier onset of disease (6,7). This linking
of polyQ aggregation to neurodegenerative disorders serves
as a powerful motivation to better understand the molecular
architecture of these aggregates.
Over the past decade, progress has been made toward
clarifying the three-dimensional structural arrangement of
several other amyloid fibrils, due to application of new
experimental techniques (8–11), but the structures of polyQ
amyloids have remained elusive. The main obstacle has
been the polymorphism and the high insolubility of theseSubmitted January 23, 2014, and accepted for publication March 25, 2014.
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0006-3495/14/05/2134/9 $2.00polypeptides, beginning even with molecules of <10 resi-
dues (12–14). Solubilization of these polyQ molecules and
conferring the ability to form well-ordered fibrils requires
the addition of flanking charged residues (12,15). Using
these modified polyQ constructs, it was established that
like other amyloids, the polyQs form cross-b structures
(15), and electron microscopy (EM) images have revealed
a variety of ribbon-like fibrils or bundles thereof (6,16).
However, these constructs still cannot produce well-
dispersed and well-ordered fibrils for high quality EM and
image analysis.
A substantive step forward has been an account of the
packing of glutamine side chains within b-structured aggre-
gates. Initially, Perutz and colleagues (15) suggested that the
side chains along with the b-structured backbone help to
stabilize the aggregates and they introduced the term gluta-
mine-zipper. Subsequent x-ray diffraction analysis estab-
lished the arrangement of H-bonded glutamine side chains
within b-crystalline assemblies (17,18). In them, the gluta-
mine side chains form H-bonded ladders, which protrude
from the planes of the b-sheets and interdigitate tightly to
bring the b-sheets together. Within the b-sheets, the chains
can be arranged in either a parallel or an antiparallel manner.
Notwithstanding, the overall folds of polyQ chains in
amyloid fibrils remained poorly understood. At first, a
water-filled nanotube model was suggested in which the
b-sheets are strongly curved (19). However, such nanotubes
should have a lumen visualizable by negative staining,http://dx.doi.org/10.1016/j.bpj.2014.03.047
Conformational Switching in PolyGln Fibrils 2135which is not the case. In other work, it was shown that
45-residue polypeptides with repeats of PGQ9 and PGQ10
fibrillized as efficiently as Q45 (12). The corresponding
PGQ7 and PGQ8 polypeptides assembled less readily,
whereas introducing one additional proline residue (nor-
mally incompatible with a b-strand conformation (20)) in
the center of the Q9 element of PGQ9 completely blocked
assembly. Polypeptides with PDGQ9 repeats aggregated
even more efficiently than PGQ9. These observations sug-
gested that the disease-related polyQ-containing amyloids
consist of alternating b-strands and turns with an optimal
repeat length of 11–12 residues. It was also suggested that
the polyQ chains have an antiparallel b-meander fold (12).
A parallel b-helix model (now also called a b-solenoid
(21)) was also proposed (12). Later, a parallel superpleated
b-structure was proposed for several amyloid fibrils (e.g.,
Ure2p and Sup35p, a-synuclein, amylin) and, in particular,
for polyQ regions of huntingtin (22). Such arrangements are
stacks of polypeptide chains composed of several b-strands
connected by loops and zigzagging in a planar serpentine
fold. Unlike in b-meanders, in superpleated b-structures
the b-strands are relatively rotated by 90 around their
axes so that they interact via the side chains, not via the
polypeptide backbones. When the serpentines stack, their
b-strands are integrated into different b-sheets. The minimal
motif for such a structure is a strand-loop-strand called a
b-arch (11). Other studies accounted for the x-ray patterns
of polyQ crystallites as slab-like b-structures, 2–3 nm thick
in the b-strand direction. The slab thickness indicated that
the polypeptide should form b-strands of ~7–8 residues
separated by reverse turns. It was suggested that polyQ
b-crystallites may consist of b-arches (17,18). Recently,
based on solid-state NMR spectroscopy data, it has been
suggested that polyQ37 and polyQ54 peptides form amyloids
compatible with the superpleated b-structure with the
b-strands assembled in antiparallel fashion (23). An antipar-
allel arrangement of polyQ b-strands was also suggested by
electron paramagnetic resonance spectroscopy (24).
However, further experimental evidence is still needed
to explain how long polyQ runs are accommodated in amy-
loid fibrils. Native polyQ polypeptides have extremely poor
solubility and structural polymorphism, and each polypep-
tide can assemble into various arrangements of b-structure
due to lack of any limiting factor. These challenges have
to be resolved to produce well-ordered polyQ fibrils suitable
for high quality microscopy. In this study, we designed syn-
thetic polyQ polypeptides adapted by the insertion of
charged and D-amino acids to elevate solubility and most
importantly to improve homogeneity by restricting the
length of each b-strand. It was intended that each polypep-
tide would fold into three b-strands of a definite length and
therefore form fibrils of consistent structure amenable to
structural analysis. Our data show that they form amyloid
fibrils and are consistent with superpleated and b-solenoid
folds, with only the addition of a single Q in the centralsequence favoring a switch between these two
conformations.METHODS
Peptide synthesis
Polypeptides were synthesized using an Fmoc-continuous flow apparatus
(Pioneer, Applied Biosystems, Foster City, CA) starting from preloaded
Fmoc-Lys(tBoc)-PEG-PS resins at a 0.2 mmol scale. The coupling reac-
tions were performed with 0.5 M of HATU (1-[Bis (dimethylamino)meth-
ylene]-1H-1,2,3-triazolo[4,5-b]pyridinium 3-oxid hexafluorophosphate in
the presence of 1 M DIEA (diisopropylethylamine). Protecting group
removal and final cleavage from the resin were carried out with TFA/
phenol/H2O/Triisopropylsilane (88/5/5/2.5%) during 4 h in both cases.
The crude polypeptides were purified by reversed phase-high performance
liquid chromatography on a C18 column (Interchrom UP5 WOD/25M
Uptispere 300 5 ODB, 250  21.2 mm). Correctness of the synthesis was
confirmed by electrospray ionization mass spectrometry.In vitro fibril assembly
Lyophilized polypeptide was dissolved in an aqueous solution of 10 mM
sodium phosphate or triethylamine (TEA) with 150 mM sodium chloride
at pH in the range of 11–12, at a final protein concentration of
5–10 mg/mL. Fibrils typically formed within a few hours but samples
were routinely incubated for at least 16 h at room temperature to ensure
that formation of fibrils was complete. The best assembly conditions for
EM and scanning transmission electron microscopy (STEM) were deter-
mined to be TEA buffer at pH 11.8.Negative staining EM
Specimens were prepared by adsorbing 5-ml drops on to freshly glow-
discharged continuous carbon film-bearing grids (Electron Microscopy
Science, Hatfield, PA), rinsing with water, and staining with 1% w/w uranyl
acetate, and then examined in a CM120 microscope (FEI, Hillsboro, OR)
operated at 120 kV. Fibril diameters were measured from digitized nega-
tives (at 1.41 A˚/pixel), using Bsoft (25,26). Fibrils were segmented into
boxes of 200 pixels along the fibrillar length and 150 pixels across, and
profiles calculated by axial averaging. Individual profiles (103 segments
of PolyQKd-32, 79 segments of PolyQKd-33) were aligned and averaged.
Diameters were measured by applying the full width at half-maximum
(FWHM) criterion for edge detection criterion. The experimental uncer-
tainty quoted is the difference between values obtained for two indepen-
dently analyzed half-data sets.Electron diffraction
Fibrils in TEA buffer were desalted in a 0.5 mL microcentrifugal filter
with 10k MWCO membrane (Millipore, Billerica, MA). Specimens were
prepared by applying drops of 0.5–2 ml to freshly glow-discharged
carbon-coated grids, washing with water, blotting, and air-drying. Diffrac-
tion patterns were taken from areas of 6 mm diameter with doses of 1–4
e/A˚2. Diffraction spacings were calibrated with evaporated thallium chlo-
ride (Electron Microscopy Science, Hatfield, PA).Cryo-EM
4 ml drops of sample were adsorbed to freshly glow-discharged holey car-
bon film-bearing grids (Quantifoil, Grosslo¨bichau, Germany), blotted, and
vitrified by plunging into liquid ethane on a Vitrobot cryo-station (FEI).Biophysical Journal 106(10) 2134–2142
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with a Gatan 626 cryo-holder (Gatan, Pleasanton, CA). The images were
recorded on film (SO-163, Kodak) and digitized at 1.67 A˚/pixel with a Su-
per CoolScan 9000 ED scanner (Nikon, Melville, NY). Fibrils from images
with similar defocus values (~2.7 mm) were selected, corrected for contrast
transfer by phase-flipping, and computationally straightened using Bsoft
(25,26) and RUBY-HELIX (27). Density profiles were obtained by aver-
aging the densities along computationally straightened fibrils. 18 fibrils,
totaling ~1 mm in length, were used in this calculation from PolyQKd-32,
and 13 from PolyQKd-33. Fibril diameters and estimated margins of error
were measured from these data as described below (Results).FIGURE 1 Schematic representation of the designed peptides. K, KD,
and S denote location of L-lysine, D-lysine, and L-serine, respectively.
The remaining positions are occupied by L-glutamines, which are not
denoted by letters, for greater clarity. The peptide shown in the scheme is
PolyQKd-33. The peptide PolyQKd-32 has one less L-Gln in the middle
section. The angles between b-strands indicated by dashed lines are arbi-
trary.STEM
Fibrils were assembled in TEA buffer, buffer exchanged to water, and then
prepared for STEM dark-field imaging according to standard procedures of
the Brookhaven STEM facility (28,29). Tobacco mosaic virus was included
to serve as an internal mass-per-length standard (131.4 kDa/nm). Typically,
a 2 ml drop of specimen was adsorbed for 1 min, the grid was washed 10
times with water, and then blotted and plunged into liquid nitrogen slush.
The grid was freeze-dried overnight with gradual warming to 80C and
then transferred under vacuum into the STEM. Dark-field digital micro-
graphs were recorded at raster steps of 1.0 and 2.0 nm per pixel. These im-
ages were analyzed using PCMass32 (available from the Brookhaven
STEM resource, ftp.stem.bnl.gov) and Bsoft (25,26). Boxes 52 nm long
and 10 nm wide were used for the measurements. Histograms were calcu-
lated from these data. In each case, a Gaussian distribution was fitted to the
main peak using Kaleidagraph (Reading, PA). To obtain more finely
sampled transverse density profiles, the data were converted to Vernier sam-
pling (30,31) at 0.33 nm per bin with the Total1D tool in the PIC image
processing software package (32). A box size of 20 pixels long (at
1 nm/pixel) by 25 pixels across was used for measurement (32 boxes for
PolyQKd-32 and 30 for PolyQKd-33). Again, edges were defined using
the FWHM method and the experimental uncertainty as the difference be-
tween the values obtained from two independently analyzed half-data sets.Molecular modeling
Fibril models were built using the BIOPOLYMER module of INSIGHT II
(Accelrys, San Diego, CA) (33). The resulting structures were subjected to
300 steps of minimization based on the steepest descent algorithm with the
H-bond distance constraints set at K¼ 50, to improve the H-bond geometry.
The next 500 steps of refinement were performed by using the conjugate
gradients algorithm. To allay concern that the H-bond constraints generated
significant tensions in the energy-minimized structure, the last calculation
was performed without any restrictions. The DISCOVER module of
INSIGHT II, the consistent valence force field, and the distance-dependent
dielectric constant were used. The program PROCHECK (34) was used to
check the quality of the modeled structure.RESULTS
Molecular design
The 33-residue polypeptide PolyQKd-33 was intended to
have three b-strands separated by two bends (Fig. 1). To
insert bends, we introduced D-lysine at positions 10 and
21. D-lysine forces a b-strand to bend via strong steric hin-
drance to continuing the strand. The putative bends divide
the polypeptide into segments of length ~8 residues (when
two turns are allowed), suggested by previous work (12)
to be optimal for polyQ-based b-strands. The second poly-Biophysical Journal 106(10) 2134–2142peptide (PolyQKd-32) differs only in the removal of one
glutamine from the region between the two bends. If indeed
this region were to form a b-strand, there should be a rela-
tive rotation of 180 between its ends, vis-a-vis PolyQKd-
33, which might affect fibrillation. Finally, four additional
L-Lys residues were inserted into the polyQ segments to
make the polypeptides soluble at pH values below 11 (the
pKa of Lys).PolyQKd peptides form well-dispersed fibrils at
high pH
PolyQKd-32 and -33 have similar physical and biochemical
behaviors. They are soluble in buffers at neutral pH,
and fibril assembly was achieved on raising the pH to
11.5–12.0 in 10 mM sodium phosphate and 150 mM
sodium chloride. The optimal pH for assembly was deter-
mined to be ~11.8, at which fibrils formed gradually over
several hours, with minimal aggregation. Similar results
were obtained when assembly was performed in TEA, a vol-
atile organic buffer that is suitable for STEM analysis.
In conventional EM images of negatively stained prepara-
tions, fibrils were typically observed to be long (>1mm),
gently curved, and smooth-sided, and with no indication
of an axial lumen (Fig. 2, A–D). Sometimes they pair into
two or more closely associated fibrils that run together for
considerable distances before separating. We measured the
widths of the basic (single-stranded) fibrils to be 4.51 5
0.23 nm for PolyQKd-33 and 5.22 5 0.39 nm for Pol-
yQKd-32.
Cryo-EM (Fig. 2, E–H), gave similar impressions of fibril
morphology. From these images, the fibril width was
measured to be 3.86 5 0.13 nm for PolyQKd-33 fibrils,
whereas PolyQKd-32 fibrils were 4.185 0.33 nm in width.
Thus, both EM techniques consistently indicated a slightly
larger diameter for PolyQKd-32 fibrils.
FIGURE 2 Images of in vitro-assembled
PolyQKd-32 and PolyQKd-33 fibrils. Electron
micrographs of negatively stained and vitrified
PolyQKd-32 (A, B and E, F) and PolyQKd-33
fibrils (C, D and G, H), respectively with their cor-
responding averaged density profiles (arrows mark
operationally defined edges). The scale bars shown
in the density profiles are 5 nm. Scale bars indicate
100 nm in A, C, E, G and 10 nm in B, D, F, H.
Conformational Switching in PolyGln Fibrils 2137Electron diffraction confirmed the presence of cross-b
structure. Specimens of both PolyQKd-32 and PolyQKd-
33 fibrils yielded a strong diffraction ring at a spacing of
0.47 nm, the hallmark of cross-b structure (Fig. 3). We
would point out that the PolyQKd electron diffraction
patterns do not have the reflection at a spacing of ~1.0 nmFIGURE 3 Electron diffraction patterns and corresponding electron
micrographs of unstained fibrils. (A) PolyQKd-33 fibrils and (B)
PolyQKd-32 fibrils. The scale bar of 200 nm applies to both EM images.
The ring in the diffractograms is at a spacing of 0.47 nm.that sometimes is observed on the amyloid diffraction pat-
terns. This reflection comes from lateral packing of b- sheets
and is generally fainter and broader than the 0.47 nm merid-
ional reflection. In many cases, the 1.0 nm reflection is
observed only faintly if at all, unless there are many fibrils
packed together and are regularly equispaced in bundles.
That was not the case with our EM specimens.Mass-per-length difference between PolyQKd-32
and PolyQKd-33 fibrils
To further characterize the fibril structures, we performed
mass-per-length analysis (MPL) by STEM (35). Specimens
were prepared by buffer exchange from assembly buffer
(TEA) to water, adsorption to the carbon support film,
further water-washing, and then freeze-drying. We observed
that buffer-exchanged specimens had markedly cleaner and
more uniform backgrounds than specimens prepared
directly from TEA buffer at pH 11.8. For optimal results,
the buffer-exchange to water has to be done gently and
immediately before grid preparation. Any physical distur-
bance or protracted storage in water (>24 hours) causes
fibril aggregation.
From the STEM images, we measured the MPL from
many fibrils of both constructs: only fibrils that were clearly
single stranded were included in this analysis (Fig. 4, Fig. 5,
A and B ). In both cases, a symmetric unimodal distribution
was obtained. From these data, we obtained a value of
12.93 5 1.69 kDa/nm for the mean linear density of
PolyQKd-32 fibrils and 9.57 5 1.23 kDa/nm for the
PolyQKd-33 fibrils (Fig. 5, C and D). In considering
possible models of cross-b structures, it is convenient toBiophysical Journal 106(10) 2134–2142
FIGURE 4 STEM images of in vitro assembled fibrils. STEMmicrographs of (A) PolyQKd-32 and (B) PolyQKd-33 fibrils with clean background, typical
of those used for mass-per-length measurements. Scale bar ¼ 10 nm.
2138 Huang et al.consider MPL values expressed in terms of numbers of
subunits per axial repeat (0.47 nm), given the molecular
mass of the monomer (3954.3 and 4082.4 Da for
PolyQKd-32 and -33, respectively). Thus, the MPL of
PolyQKd-32 was determined to be 1.54 5 0.20 subunits
per axial repeat, and that of PolyQKd-33 fibrils as 1.10 5
0.14 subunits per repeat.Biophysical Journal 106(10) 2134–2142For the STEM images acquired, the electron probe, which
is ~0.3 nm in diameter, sampled the specimen at intervals of
2 nm per pixel and some at 1 nm per pixel. This sampling
rate ensures minimal mass loss and is therefore suitable
for determining MPLs accurately (29). However, it is too
coarse for precise measurement of the diameters of fibrils
as thin as these polyQ fibrils. To obtain averaged transverseFIGURE 5 STEM microscopy and mass-per-
length analysis. STEM micrographs of PolyQKd-
32 (A) and PolyQKd-33 (B) fibrils with their
corresponding transverse density profiles. Scale
bar ¼ 10 nm on micrographs and 5 nm on the
density profiles (arrows mark operationally
defined edges). Measurements were made only
from uniform thin and apparently single-stranded
regions, such as those delimited by white arrows.
The regions marked by diamonds are thicker
bundled fibril. Tobacco mosaic virus indicated by
an asterisk was used as an internal calibration
reference. (C) The distribution of PolyQKd-32
measurements has a mean at 1.545 0.20 subunits
per axial step (0.47nm), N¼ 780. (D) The distribu-
tion of PolyQKd-33 measurements has a mean at
1.10 5 0.14 subunits per axial step, N ¼ 816
(see also Fig. 4).
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pixel), the data were resorted computationally by Vernier
sampling (31), Fig. 5, A and B, and the respective widths
were measured. According to these data, the PolyQKd-32
fibrils (5.94 5 0.66 nm) are slightly but significantly
thicker than the PolyQKd-33 fibrils (4.625 0.33 nm) con-
firming the trend already detected by negative staining and
cryo-EM.FIGURE 7 Superpleated b-structure models of PolyQ amyloid fibrils
built from three b-structured modules each with three strands (arrows)
and two turns. Lines between b-strands denote H-bonds. The polyQ chains
can be arranged in two antiparallel (left, and center) or a parallel manner
(right). Molecular modeling favors antiparallel stacking type 2 (data not
shown) where positively charged Lys is located at greater distances and
this diminishes the electrostatic repulsions. Moreover, in the antiparallel
arrangement type 1, b-arcs that are packed one over the other have steric
tensions.Structural interpretation
To interpret the experimental data, we used the following
precepts. First, in a fibril, each polypeptide should have
the same conformation and engage in equivalent interac-
tions (10,11). Second, there should be bends at the positions
of the D-amino acids and, as a result, the building-blocks
should have three b-strands with two bends. Taken in the
context of cross-b arrangements, these constraints lead us
to three possible basic models: i), b-meanders; ii), b-sole-
noids; or iii), b-serpentines (Fig. 6).
We interpret the STEM data as showing that the
PolyQKd-33 fibrils have one subunit per axial step, as do
many other amyloids (35,36). The small discrepancy is dis-
cussed further below. The average fibril diameter observed
by negative staining, cryo-EM, and STEM is in the range
of 4 to 6 nm in each case. These data are well explained
by a superpleated model with three b-sheets. As discussed
further below, these b-sheets might be parallel (Fig. 6 C)
or antiparallel (Fig. 7). Modeling shows a cross section
resembling a 2.9 3.7 nm rectangle with 4.7 nm in diagonal
(see Fig. 8 B). These dimensions are in good agreement
with the experimental measurements for the average diam-FIGURE 6 Models of amyloid fibrils built from three b-structured
modules, each with three strands (arrows) and two turns. Lines between
b-strands denote H-bonds. (A) b-meander model having three side-by-
side b-sheets. Its width is between 2.7 and 3.7 nm and expected MPL is
one molecule per cross section. In principle, b-meanders from the neigh-
boring b-sheets can be axially displaced. (B) A b-solenoid model in a par-
allel conformation with estimated width of 1.8 to 3.7 nm and 2/3 molecule
per fibril cross section. (C). A superpleated b-structure model in a parallel
conformation with width of 2.9 to 3.7 nm and one molecule per fibril cross
section.eter: 4.5 nm by negative staining, 3.9 nm by cryo-EM, and
4.6 nm by STEM (Table 1). This concurrence further sup-
ports this model.
As for the other candidates, the closest b-solenoid model,
with two b-strands per turn giving two subunits in three
steps of the 0.47 nm repeat (Fig. 6 B), predicts an MPL of
0.67 subunits per axial repeat. This does not satisfy the
STEM data. An alternative model, with three long b-sheets
packed side by side and formed by stacks of H-bonded
b-meanders (Fig. 6 A) does fit the MPL and width data,
but does not explain why lateral growth of the stack should
be limited to three b-meanders. Moreover, the lysines in the
central b-sheet would be buried in close proximity in the
fibril core and their mutual electrostatic repulsion makes
this model even less plausible.
For PolyQKd-32 fibrils, the STEM MPL measurements
give 1.54 5 0.20 peptides per 0.47 nm axial repeat. These
data cannot be explained by models with protofibrils having
superpleated b-structures as they give only integral numbers
of molecules per axial repeat (1, 2, etc.). They can, in prin-
ciple, be explained by a b-meander model with a 4-sheet
stack giving 1.33 subunits per axial repeat and an estimatedTABLE 1 Summary of measurements by all EM methods
Diameter (nm)
MPL
(subunits /
0.47nm)
Methods Negative
staining EM
Cryo-EM STEM STEM
PolyQKd-32 5.225 0.39 4.185 0.33 5.945 0.66 1.545 0.20
PolyQKd-33 4.515 0.23 3.865 0.13 4.625 0.33 1.105 0.14
Difference 13.6 (%) 7.7 (%) 22.2 (%) n/a
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limits to lateral growth and the burying of lysines make this
model improbable. The data also disagree with a single
b-solenoid protofibril model with 0.67 subunits per cross
section, i.e., 1.5 turns of the solenoid per subunit (Fig. 6
B), but a model with two such closely associated b-solenoid
protofibrils and 1.33 peptides per cross section agrees with
the MPL data to within experimental error. Furthermore,
the predicted dimensions of such model are ~3.6 
3.7 nm in cross section with 5.2 nm on diagonal
(Fig. 8 A), fitting the experimental data (5.2 nm by negative
stain; 4.2 nm in cryo-EM; 5.9 nm by STEM, Table 1).FIGURE 8 Ribbon representations (axial and lateral views) of structural
models of PolyQKd-32 and PolyQKd-33 fibrils. Sequence motifs of b-arcs
fit well blbbl conformation (41) (where b is b-conformation and l is left-
handed a-conformation of residues). First, the D-lysine in the 10th and
21st positions of each b-arc should favor required left-handed a-conforma-
tion. Second, because uncompensated charges inside the protein strongly
destabilize the structure, D-lysines in the 10th and 21st positions and
L-lysines in the 13th and 24th positions should be on the surface of the
engineered fibrils when the bends have the blbbl-arc. Third, for the inside
positions of such b-arcs (positions 11, 14 and 22, 25) small serine was
selected because this residue is frequently located there in the known
blbbl-arcs. The modeled structures do not have steric tensions and donors
and acceptors of H-bonds interact with each other or having the possibility
to bind water molecules. In accordance with PROCHECK output, the over-
all average G-factor of the models are ~0.50, a value typical for a good qual-
ity model.
Biophysical Journal 106(10) 2134–2142The models proposed provide a simple explanation for
the major change in MPL of the fibrils that accompanies
insertion of a single amino acid. Both models have b-arches
and zipper packing of glutamine side chains and differ only
in the overall arrangement of the b-arches.DISCUSSION
Experimental uncertainty—EM measurements of
fibril thickness
In each case—negative staining transmission electronmicro-
scopy, cryo-EM, and STEM of unstained freeze-dried speci-
mens—noise in the calculated density profilewas suppressed
by extensive averaging. However, the three kinds ofmeasure-
ments are subject to different sources of experimental uncer-
tainty.Moreover, the actual numbers obtained for fibril width
necessarily depend on the edge detection criterion employed.
In negative staining, the principal uncertainty relates to how
far the protein structure penetrates into the stain bed that has
accumulated along the edges and may be complicated by
some positive staining. For these measurements we used
the FWHM criterion. The same criterion was applied to the
STEM data where apparent width is likely to be exaggerated
somewhat by curvature in the filament segments analyzed
and imperfect alignment of the sampling boxes with the fibril
edges.With cryo-EMdata, there is residual negative interfer-
ence fringes along the edges despite the contrast transfer
function correction applied and we define, operationally,
the edges as the points at which the profile first falls to the
background level defined outside the interference fringes.Experimental uncertainty—numbers of subunits
per axial step
A STEM determination of MPL involves making measure-
ments from a sizeable set of fibril segments, compiling a his-
togram, and—provided that the resulting distribution is
symmetrical and there are no other indications of multiple
species—fitting a Gaussian curve. The position of its
mean is the MPL determination for that data set. In princi-
ple, the experimental uncertainty could be made arbitrarily
small by adding more and more data. However, there are
numerous potential sources of systematic error that may
vary somewhat from experiment to experiment, making it
difficult to achieve an absolute degree of reproducibility.
These factors have been reviewed by Goldsbury et al.
(35), who concluded that a residual discrepancy of 5–10%
between the measured value and the actual value is typical.Relationship between the designed peptides and
native polyQ containing amyloids
Bare polyQ polypeptides are not found in vivo (2): rather,
the polyQ tracts are parts of longer proteins with other
Conformational Switching in PolyGln Fibrils 2141domains, which are likely to interfere by steric hindrance
with the addition of subunits to the ends of growing fibrils
and thus with the assembly of well-ordered fibrils (37).
Furthermore, native polyQ-containing proteins do not
contain any D-amino acids in their polyQ tracts that would
restrict the lengths of b-strands. These considerations sug-
gest that the fibrillar organization in native polyQ-contain-
ing amyloids is in general less regular than in the fibrils
we have engineered, but we posit that they polymerize
accordingly to much the same set of interactions as the
fibrils that we have studied in vitro.Parallel or antiparallel arrangements
As discussed previously, a superpleated model with three
b-sheets complies with all current constraints on the
PolyQKd-33 fibril. At this time, we see no compelling argu-
ment in favor of a parallel or an antiparallel arrangement.
On one hand, a study of three polyQ-containing polypep-
tides by solid-state NMR spectroscopy favored antiparallel
structures (23). However, those constructs were of different
lengths and had different non-Q components than the fibrils
studied here and the fibrils were all much wider than those
assembled in this study. We have also performed molecular
modeling that favors antiparallel stacking type 2 (Fig. 7)
because the positively charged Lys residues are spaced
further apart, diminishing the electrostatic repulsions (A.
Kajava, unpublished results).
On the other hand, there are an already substantial num-
ber of amyloid fibrils in which parallel b-sheets have been
demonstrated. Examples include the yeast prion filaments
Ure2p (38) and Sup35p (39) whose fibrillizing domains
are rich in Q and N, and the fungal prion Het-s (40). More-
over the model for the PolyQKd-32 fibril, a polypeptide so
like PolyQKd-32 in many respects, has an unambiguously
parallel arrangement.CONCLUSIONS
Numerous in vitro studies have used synthetic polypeptides
to investigate polyQ aggregation. The resulting aggregates
can vary in structure from clumps to gels to fibrillar net-
works. The best way to mimic the natural fibril arrangement
with synthetic polypeptides is to design modifications that
favor polymerization into fibrils rather than clumps or
gels. In this study, we found a way to do so, designing poly-
peptides that form well dispersed amyloid fibrils suitable for
microscopy studies. Our experimental data show that the
deletion of just one glutamine residue from the middle of
the 33-residue peptide leads to a substantially different am-
yloid structure. This effect is explained in a straightforward
way by two b-arch-containing models. The present results
provide insight into the molecular architecture of PolyQ
fibrils, and further support the conception of b-arch com-
monality in amyloid fibril structures. They also open newpossibilities for structure-based design of drugs inhibiting
fibril growth.
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